Last updated on December 2019

A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma

Brief description of study

The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC).


Clinical Study Identifier: TX223524

Find a site near you

Start Over


Located in: PARIS, France
  Connect »